Dermatitis - atopic and Wound secretion
Summary:
Wound secretion is found among people with Dermatitis - atopic, especially for people who are female, 30-39 old.
The study analyzes which people have Wound secretion with Dermatitis - atopic. It is created by eHealthMe based on reports of 44 people who have Dermatitis - atopic from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Dermatitis - atopic?
Dermatitis - atopic (inflammatory, chronically relapsing, non-contagious and pruritic skin disorder) is found to be associated with 1,988 drugs and 1,974 conditions by eHealthMe. Check the latest studies of Dermatitis - atopic.
What is Wound secretion?
Wound secretion is found to be associated with 571 drugs and 759 conditions by eHealthMe. Check the latest studies of Wound secretion.
44 people who have Dermatitis - Atopic and Wound Secretion are studied.

Gender of people who have Dermatitis - Atopic and experienced Wound Secretion *:
- female: 53.66 %
- male: 46.34 %
Age of people who have Dermatitis - Atopic and experienced Wound Secretion *:
- 0-1: 0.0 %
- 2-9: 10.0 %
- 10-19: 6.67 %
- 20-29: 6.67 %
- 30-39: 56.67 %
- 40-49: 6.67 %
- 50-59: 10.0 %
- 60+: 3.33 %
Common co-existing conditions for these people *:
- Seasonal Allergy (allergic condition due to certain season): 9 people, 20.45%
- Osteoporosis (bones weak and more likely to break): 9 people, 20.45%
- Migraine (headache): 9 people, 20.45%
- Irritable Bowel Syndrome: 9 people, 20.45%
- Asthma: 9 people, 20.45%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 7 people, 15.91%
Common drugs taken by these people *:
- Ventolin: 10 people, 22.73%
- Gaviscon: 9 people, 20.45%
- Zoledronic Acid: 9 people, 20.45%
- Paracetamol: 9 people, 20.45%
- Intal: 8 people, 18.18%
- Zopiclone: 5 people, 11.36%
- Elidel: 5 people, 11.36%
- Hydroxyzine: 5 people, 11.36%
- Triamcinolone: 3 people, 6.82%
- Vitamin D: 2 people, 4.55%
Common symptoms for these people *:
- Rashes (redness): 21 people, 47.73%
- Itching: 20 people, 45.45%
- Insomnia (sleeplessness): 15 people, 34.09%
- Pain: 13 people, 29.55%
- Skin Exfoliation (removal of the oldest dead skin cells): 13 people, 29.55%
- Hair Loss: 11 people, 25.00%
- Steroid Withdrawal Syndrome (dizziness, fatigue, gastrointestinal problems, and headaches after stop taking steroids): 11 people, 25.00%
- Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 10 people, 22.73%
- Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 10 people, 22.73%
- Hypoaesthesia (reduced sense of touch or sensation): 8 people, 18.18%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Wound secretion?
- Check whether Wound secretion is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Dermatitis - atopic (61,311 reports)
- Wound secretion (5,127 reports)
All the drugs that are associated with Wound secretion:
- Wound secretion (571 drugs)
All the conditions that are associated with Wound secretion:
- Wound secretion (759 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Wound secretion and Dermatitis - atopic, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Salivary Hypersecretion and drugs of ingredients of sertraline hydrochloride - a second ago
- Photophobia and drugs of ingredients of didanosine - 4 seconds ago
- Thrombocytopenia and drugs of ingredients of codeine sulfate - 7 seconds ago
- Peg-Intron and Renal Failure Acute for Women aged 50-59 - 10 seconds ago
- Peg-Intron and Renal Failure for Women aged 50-59 - 10 seconds ago
- Peg-Intron and Kidney Failure for Women aged 50-59 - 10 seconds ago
- Peg-Intron and Arf for Women aged 50-59 - 10 seconds ago
- Peg-Intron and Acute Kidney Failure for Women aged 50-59 - 11 seconds ago
- Giardiasis and drugs of ingredients of methotrexate sodium - 25 seconds ago
- Pvt and drugs of ingredients of calcitriol - 33 seconds ago